SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients
- PMID: 33915005
- DOI: 10.1111/tid.13628
SARS-CoV-2 infection after two doses of mRNA vaccine in renal transplant recipients
Keywords: COVID-19; SARS-CoV-2; renal transplantation; vaccination.
Comment on
-
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.Kidney Int. 2021 Jun;99(6):1487-1489. doi: 10.1016/j.kint.2021.03.014. Epub 2021 Mar 26. Kidney Int. 2021. PMID: 33775674 Free PMC article. No abstract available.
References
REFERENCES
-
- Mahalingasivam V, Craik A, Tomlinson LA, et al. A Systematic Review of COVID-19 and Kidney Transplantation. Kidney Int Rep. 2021;6(1):24-45.
-
- ECDC. COVID-19 vaccination and prioritization strategies in the EU/EEA. https://www.ECDC.europa.eu/sites/default/files/documents/COVID-19-vaccin...
-
- Danziger-Isakov L, Kumar D. Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):e13563.
-
- Eckerle I, Rosenberger KD, Zwahlen M, Junghanss T. Serologic vaccination response after solid organ transplantation: a systematic review. PLoS One. 2013;8(2):e56974.
-
- Bentomane I, Gautier-Vargas G, Cognard N, et al. Weak anti-severe acute respiratory syndrome coronavirus 2 antibody response after the first injection of an mRNA Coronavirus Disease 2019 vaccine in kidney transplant recipients. Kidney Int. 2021. In press.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
